Both in Biotechnology
Neurocrine Biosciences vs Halozyme Therapeutics
Over the past year NBIX returned +16.0% and HALO returned +91.5%; their daily moves had a correlation of 0.28.
NBIX +16.0% HALO +91.5%Growth of $1, one year, split-adjusted
| Metric | NBIX | HALO |
|---|---|---|
| Price | $166.05 | $130.34 |
| Market cap | $16.88B | $14.79B |
| Today | +0.73% | +1.34% |
| 1 month | +14.1% | +18.8% |
| 6 months | +12.9% | +96.4% |
| Year to date | +17.1% | +93.7% |
| 1 year | +17.0% | +96.9% |
| Revenue growth (YoY) | +41.2% | +47.7% |
| Gross margin | 97.6% | 83.5% |
| Net margin | 18.4% | 47.8% |
| P/E (TTM) | 24.0× | 35.8× |
| Price / sales | 4.6× | 8.9× |
| Net cash | $737.9M | -$1.92B |
| Dividend yield | — | — |
| Volatility (60d) | 36.5% | 27.9% |
| Short % of float | 6.6% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).